Results 21 to 30 of about 54,777 (206)

Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review

Acta Médica Portuguesa, 2020
Introduction: Human papillomavirus is responsible for almost all cases of cervical cancer, an important portion of anogenital and oropharyngeal invasive and preinvasive lesions, as well as genital warts (condyloma acuminatum) and recurrent respiratory ...
Rita Medeiros, Susan Vaz, Teresa Rebelo, Margarida Figueiredo-Dias   +3 more
doaj   +1 more source

Cervical Cancer-Associated Human Papillomavirus 16 E7 Oncoprotein Inhibits Induction of Anti-Cancer Immunity by a CD4+ T Cell Dependent Mechanism [PDF]

, 2009
Attempts to develop therapeutic vaccines against cervical cancer have been proven difficult. One of the major causes of the failure is due to the use of the wrong mouse models based on transplantable tumours in testing the efficacy of vaccines.
Germain J. Fernando, Jie Zhong, Marion E. G. Brunck, Xiao Song Liu   +3 more
core   +2 more sources

A novel pre-clinical murine model to study the life cycle and progression of cervical and anal papillomavirus infections. [PDF]

PLoS ONE, 2015
Papillomavirus disease and associated cancers remain a significant health burden in much of the world. The current protective vaccines, Gardasil and Cervarix, are expensive and not readily available to the underprivileged.
Nancy M Cladel, Lynn R Budgeon, Karla K Balogh, Timothy K Cooper, Jiafen Hu, Neil D Christensen   +5 more
doaj   +1 more source

Eliminat Cervical Cancer, Focusing on Primary Prevention

Zhongliu Fangzhi Yanjiu, 2023
As one of the most severe malignant tumors, cervical cancer poses a significant threat to women. In 2020, the World Health Organization (WHO) introduced the "Global Strategy to Accelerate the Elimination of Cervical Cancer" in response to well ...
ZHAO Chao, LI Mingzhu, WEI Lihui
doaj   +1 more source

Going beyond the individual: How state-level characteristics relate to HPV vaccine rates in the United States [PDF]

, 2019
Background The human papillomavirus (HPV) vaccine is an underutilized cancer control practice in the United States. Although individual contextual factors are known to impact HPV vaccine coverage rates, the impact of macro-level elements are still ...
Brownson, Ross C, Franco, Melissa, Mazzucca, Stephanie, Padek, Margaret   +3 more
core   +2 more sources

Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction [PDF]

, 2019
Examination of cross-protection and type replacement after human papillomavirus (HPV) vaccine introduction is essential to guide vaccination recommendations and policies.
Bernstein, David I., Brown, Darron, Covert, Courtney, Ding, Lili, Franco, Eduardo L., Kahn, Jessica A.   +5 more
core   +1 more source

A cohort survey of the effect of an educational intervention on human papillomavirus vaccine-related knowledge and attitudes among pre-university female students in Singapore

Proceedings of Singapore Healthcare, 2017
Introduction: Although cervical cancer is the 10th most common cancer among females in Singapore, it is a vaccine-preventable cancer. Human papillomavirus vaccines combined with regular Pap (papillomavirus) smears have been shown to reduce the mortality ...
Sarah Woon Ching Lim, Alicia Ying Ying Boo, Wee Chuan Tan, Eunice Su-Yin Png, Hang Keong Lee, Zi Ying Chang, Serene Xue Jia Wee, Brindha Balakrishnan, Kuan Siew Choong, Ian Kwong Yun Phoon   +9 more
doaj   +1 more source

Optimization of multimeric human papillomavirus L2 vaccines. [PDF]

PLoS ONE, 2013
We sought to define the protective epitopes within the amino terminus of human papillomavirus (HPV) type 16 minor capsid protein L2. Passive transfer of mice with rabbit antisera to HPV16 L2 peptides 17-36, 32-51 and 65-81 provided significant protection
Subhashini Jagu, Kihyuck Kwak, Balasubramanyam Karanam, Warner K Huh, Vijayarangam Damotharan, Sudha V Chivukula, Richard B S Roden   +6 more
doaj   +1 more source

Which primary care practitioners have poor human papillomavirus (HPV) knowledge? A step towards informing the development of professional education initiatives [PDF]

, 2018
Background: Primary care practitioners (PCP) play key roles in cervical cancer prevention. Human papillomavirus (HPV) knowledge is an important influence on PCPs’ cervical cancer prevention-related behaviours.
ATHENS (A Trial of HPV Education and Support) Group, Cara M Martin, Eamonn O'Leary, Jill J Francis, John J O'Leary, Linda Sharp, Lisa A McSherry, Stephan U Dombrowski   +7 more
core   +5 more sources

Prophylactic human papillomavirus vaccines [PDF]

Journal of Clinical Investigation, 2006
Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the second most common cause of death from cancer among women worldwide. This Review examines prophylactic HPV subunit vaccines based on the ability of the viral L1 capsid protein to form virus-like particles (VLPs) that induce high levels of neutralizing antibodies ...
Douglas R, Lowy, John T, Schiller
openaire   +2 more sources